A20 inhibition of NFκB and inflammation: targeting E2:E3 ubiquitin enzyme complexes.
作者信息
Shembade Noula, Harhaj Edward
出版信息
Cell Cycle. 2010 Jul 1;9(13):2481-2. doi: 10.4161/cc.9.13.12269.
Abstract
摘要
相似文献
1
A20 inhibition of NFκB and inflammation: targeting E2:E3 ubiquitin enzyme complexes.
Cell Cycle. 2010 Jul 1;9(13):2481-2. doi: 10.4161/cc.9.13.12269.
2
Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
Science. 2010 Feb 26;327(5969):1135-9. doi: 10.1126/science.1182364.
3
Bavachin exerted anti-neuroinflammatory effects by regulation of A20 ubiquitin-editing complex.
Int Immunopharmacol. 2021 Nov;100:108085. doi: 10.1016/j.intimp.2021.108085. Epub 2021 Aug 25.
4
MST1 Negatively Regulates TNFα-Induced NF-κB Signaling through Modulating LUBAC Activity.
Mol Cell. 2019 Mar 21;73(6):1138-1149.e6. doi: 10.1016/j.molcel.2019.01.022. Epub 2019 Feb 21.
5
Cell biology. Turning off inflammation signaling.
Science. 2010 Feb 26;327(5969):1093-4. doi: 10.1126/science.1187271.
6
CARD14 signalosome formation is associated with its endosomal relocation and mTORC1-induced keratinocyte proliferation.
Biochem J. 2024 Sep 18;481(18):1143-1171. doi: 10.1042/BCJ20240058.
7
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
J Mol Biol. 2008 Feb 15;376(2):526-40. doi: 10.1016/j.jmb.2007.11.092. Epub 2007 Dec 4.
8
The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
EMBO J. 2009 Mar 4;28(5):513-22. doi: 10.1038/emboj.2008.285. Epub 2009 Jan 8.
9
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Nature. 2004 Aug 5;430(7000):694-9. doi: 10.1038/nature02794. Epub 2004 Jul 18.
10
Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20.
Immunity. 2013 Sep 19;39(3):470-81. doi: 10.1016/j.immuni.2013.08.016. Epub 2013 Sep 5.
引用本文的文献
1
Single-cell RNA sequencing of circulating immune cells supports inhibition of and translation as psoriatic arthritis biomarkers.
Front Immunol. 2025 Feb 7;16:1483393. doi: 10.3389/fimmu.2025.1483393. eCollection 2025.
2
Airway epithelial immunoproteasome subunit LMP7 protects against rhinovirus infection.
Sci Rep. 2022 Aug 25;12(1):14507. doi: 10.1038/s41598-022-18807-3.
3
Advances in the Study of the Ubiquitin-Editing Enzyme A20.
Front Pharmacol. 2022 May 3;13:845262. doi: 10.3389/fphar.2022.845262. eCollection 2022.
4
Multifaceted roles of TAX1BP1 in autophagy.
Autophagy. 2023 Jan;19(1):44-53. doi: 10.1080/15548627.2022.2070331. Epub 2022 May 9.
5
Immune regulator LGP2 targets Ubc13/UBE2N to mediate widespread interference with K63 polyubiquitination and NF-κB activation.
Cell Rep. 2021 Dec 28;37(13):110175. doi: 10.1016/j.celrep.2021.110175.
6
Lymphotropic Viruses: Chronic Inflammation and Induction of Cancers.
Biology (Basel). 2020 Nov 10;9(11):390. doi: 10.3390/biology9110390.
7
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
Int Immunopharmacol. 2020 Dec;89(Pt B):107087. doi: 10.1016/j.intimp.2020.107087. Epub 2020 Oct 12.
8
A20 of nucleus pulposus cells plays a self-protection role via the nuclear factor-kappa B pathway in the inflammatory microenvironment.
Bone Joint Res. 2020 Jun 8;9(5):225-235. doi: 10.1302/2046-3758.95.BJR-2019-0230.R1. eCollection 2020 May.
9
Regulation of the Hippo signaling pathway by deubiquitinating enzymes in cancer.
Genes Dis. 2019 Jun 24;6(4):335-341. doi: 10.1016/j.gendis.2019.06.004. eCollection 2019 Dec.
10
TGF-β signaling pathway mediated by deubiquitinating enzymes.
Cell Mol Life Sci. 2019 Feb;76(4):653-665. doi: 10.1007/s00018-018-2949-y. Epub 2018 Oct 22.
本文引用的文献
1
Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
Science. 2010 Feb 26;327(5969):1135-9. doi: 10.1126/science.1182364.
2
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
Nature. 2009 Jun 4;459(7247):717-21. doi: 10.1038/nature07968. Epub 2009 May 3.
3
The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
EMBO J. 2009 Mar 4;28(5):513-22. doi: 10.1038/emboj.2008.285. Epub 2009 Jan 8.
4
A20: central gatekeeper in inflammation and immunity.
J Biol Chem. 2009 Mar 27;284(13):8217-21. doi: 10.1074/jbc.R800032200. Epub 2008 Nov 13.
5
The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20.
Nat Immunol. 2008 Mar;9(3):254-62. doi: 10.1038/ni1563. Epub 2008 Feb 3.
6
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
J Mol Biol. 2008 Feb 15;376(2):526-40. doi: 10.1016/j.jmb.2007.11.092. Epub 2007 Dec 4.
7
The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation.
J Virol. 2007 Dec;81(24):13735-42. doi: 10.1128/JVI.01790-07. Epub 2007 Oct 17.
8
Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5.
Nat Struct Mol Biol. 2006 Mar;13(3):264-71. doi: 10.1038/nsmb1064. Epub 2006 Feb 5.
9
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Nature. 2004 Aug 5;430(7000):694-9. doi: 10.1038/nature02794. Epub 2004 Jul 18.
10
Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity.
Biochem J. 2004 Mar 15;378(Pt 3):727-34. doi: 10.1042/BJ20031377.
Zotero 插件